BURLESON GENE E 4
4 · SUNLINK HEALTH SYSTEMS INC · Filed Aug 16, 2023
Insider Transaction Report
Form 4
BURLESON GENE E
Director
Transactions
- Award
Series C Fractional Interests
2023-08-16+81,601→ 81,601 total - Award
Series C Fractional Interests
2023-08-16+10,000→ 10,000 total(indirect: By Trust)
Holdings
- 81,601
Common Stock
- 10,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]On August 2, 2023, the Company declared a dividend per Common Share of one fractional interest in the Corporation's Series C Redeemable Preferred Shares (the "Series C Preferred Shares", and each such fraction of a Series C Preferred Share, a "Series C Fractional Interest"), for each outstanding share of the Company's common shares, no par value per share (the "Common Shares"), payable on August 16, 2023 to shareholders of record at 5:00 p.m. Eastern Time on August 15, 2023.
- [F2]This row reflects direct ownership which has not changed as a result of the transactions reported on this form.
- [F3]This row reflects indirect ownership which has not changed as a result of the transactions reported on this form.